Prescription Dermatological Medications Market - Global Outlook and Forecast 2022-2028

March 2022 | 79 pages | ID: PAED494D849AEN
Market Monitor Global

Abstracts

Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.

This report contains market size and forecasts of Prescription Dermatological Medications in global, including the following market information:

Global Prescription Dermatological Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Prescription Dermatological Medications Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Prescription Dermatological Medications companies in 2021 (%)

The global Prescription Dermatological Medications market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Prescription Dermatological Medications include Mylan Pharmaceuticals, Pfizer, Almirall, Bausch Health, Barrier Therapeutics, PharmaDerm, Bristol-Myers Squibb, Galderma and Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Dermatological Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prescription Dermatological Medications Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Prescription Dermatological Medications Market Segment Percentages, by Type, 2021 (%)

• Oral
• Topical

Global Prescription Dermatological Medications Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Prescription Dermatological Medications Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Global Prescription Dermatological Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Prescription Dermatological Medications Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prescription Dermatological Medications revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Prescription Dermatological Medications revenues share in global market, 2021 (%)

Key companies Prescription Dermatological Medications sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Prescription Dermatological Medications sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Mylan Pharmaceuticals
• Pfizer
• Almirall
• Bausch Health
• Barrier Therapeutics
• PharmaDerm
• Bristol-Myers Squibb
• Galderma
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Prescription Dermatological Medications Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Prescription Dermatological Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PRESCRIPTION DERMATOLOGICAL MEDICATIONS OVERALL MARKET SIZE

2.1 Global Prescription Dermatological Medications Market Size: 2021 VS 2028
2.2 Global Prescription Dermatological Medications Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Prescription Dermatological Medications Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Prescription Dermatological Medications Players in Global Market
3.2 Top Global Prescription Dermatological Medications Companies Ranked by Revenue
3.3 Global Prescription Dermatological Medications Revenue by Companies
3.4 Global Prescription Dermatological Medications Sales by Companies
3.5 Global Prescription Dermatological Medications Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Prescription Dermatological Medications Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Prescription Dermatological Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Dermatological Medications Players in Global Market
  3.8.1 List of Global Tier 1 Prescription Dermatological Medications Companies
  3.8.2 List of Global Tier 2 and Tier 3 Prescription Dermatological Medications Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Prescription Dermatological Medications Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Topical
4.2 By Type - Global Prescription Dermatological Medications Revenue & Forecasts
  4.2.1 By Type - Global Prescription Dermatological Medications Revenue, 2017-2022
  4.2.2 By Type - Global Prescription Dermatological Medications Revenue, 2023-2028
  4.2.3 By Type - Global Prescription Dermatological Medications Revenue Market Share, 2017-2028
4.3 By Type - Global Prescription Dermatological Medications Sales & Forecasts
  4.3.1 By Type - Global Prescription Dermatological Medications Sales, 2017-2022
  4.3.2 By Type - Global Prescription Dermatological Medications Sales, 2023-2028
  4.3.3 By Type - Global Prescription Dermatological Medications Sales Market Share, 2017-2028
4.4 By Type - Global Prescription Dermatological Medications Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Prescription Dermatological Medications Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Prescription Dermatological Medications Revenue & Forecasts
  5.2.1 By Application - Global Prescription Dermatological Medications Revenue, 2017-2022
  5.2.2 By Application - Global Prescription Dermatological Medications Revenue, 2023-2028
  5.2.3 By Application - Global Prescription Dermatological Medications Revenue Market Share, 2017-2028
5.3 By Application - Global Prescription Dermatological Medications Sales & Forecasts
  5.3.1 By Application - Global Prescription Dermatological Medications Sales, 2017-2022
  5.3.2 By Application - Global Prescription Dermatological Medications Sales, 2023-2028
  5.3.3 By Application - Global Prescription Dermatological Medications Sales Market Share, 2017-2028
5.4 By Application - Global Prescription Dermatological Medications Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Prescription Dermatological Medications Market Size, 2021 & 2028
6.2 By Region - Global Prescription Dermatological Medications Revenue & Forecasts
  6.2.1 By Region - Global Prescription Dermatological Medications Revenue, 2017-2022
  6.2.2 By Region - Global Prescription Dermatological Medications Revenue, 2023-2028
  6.2.3 By Region - Global Prescription Dermatological Medications Revenue Market Share, 2017-2028
6.3 By Region - Global Prescription Dermatological Medications Sales & Forecasts
  6.3.1 By Region - Global Prescription Dermatological Medications Sales, 2017-2022
  6.3.2 By Region - Global Prescription Dermatological Medications Sales, 2023-2028
  6.3.3 By Region - Global Prescription Dermatological Medications Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Prescription Dermatological Medications Revenue, 2017-2028
  6.4.2 By Country - North America Prescription Dermatological Medications Sales, 2017-2028
  6.4.3 US Prescription Dermatological Medications Market Size, 2017-2028
  6.4.4 Canada Prescription Dermatological Medications Market Size, 2017-2028
  6.4.5 Mexico Prescription Dermatological Medications Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Prescription Dermatological Medications Revenue, 2017-2028
  6.5.2 By Country - Europe Prescription Dermatological Medications Sales, 2017-2028
  6.5.3 Germany Prescription Dermatological Medications Market Size, 2017-2028
  6.5.4 France Prescription Dermatological Medications Market Size, 2017-2028
  6.5.5 U.K. Prescription Dermatological Medications Market Size, 2017-2028
  6.5.6 Italy Prescription Dermatological Medications Market Size, 2017-2028
  6.5.7 Russia Prescription Dermatological Medications Market Size, 2017-2028
  6.5.8 Nordic Countries Prescription Dermatological Medications Market Size, 2017-2028
  6.5.9 Benelux Prescription Dermatological Medications Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Prescription Dermatological Medications Revenue, 2017-2028
  6.6.2 By Region - Asia Prescription Dermatological Medications Sales, 2017-2028
  6.6.3 China Prescription Dermatological Medications Market Size, 2017-2028
  6.6.4 Japan Prescription Dermatological Medications Market Size, 2017-2028
  6.6.5 South Korea Prescription Dermatological Medications Market Size, 2017-2028
  6.6.6 Southeast Asia Prescription Dermatological Medications Market Size, 2017-2028
  6.6.7 India Prescription Dermatological Medications Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Prescription Dermatological Medications Revenue, 2017-2028
  6.7.2 By Country - South America Prescription Dermatological Medications Sales, 2017-2028
  6.7.3 Brazil Prescription Dermatological Medications Market Size, 2017-2028
  6.7.4 Argentina Prescription Dermatological Medications Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Prescription Dermatological Medications Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Prescription Dermatological Medications Sales, 2017-2028
  6.8.3 Turkey Prescription Dermatological Medications Market Size, 2017-2028
  6.8.4 Israel Prescription Dermatological Medications Market Size, 2017-2028
  6.8.5 Saudi Arabia Prescription Dermatological Medications Market Size, 2017-2028
  6.8.6 UAE Prescription Dermatological Medications Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Mylan Pharmaceuticals
  7.1.1 Mylan Pharmaceuticals Corporate Summary
  7.1.2 Mylan Pharmaceuticals Business Overview
  7.1.3 Mylan Pharmaceuticals Prescription Dermatological Medications Major Product Offerings
  7.1.4 Mylan Pharmaceuticals Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.1.5 Mylan Pharmaceuticals Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Prescription Dermatological Medications Major Product Offerings
  7.2.4 Pfizer Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.2.5 Pfizer Key News
7.3 Almirall
  7.3.1 Almirall Corporate Summary
  7.3.2 Almirall Business Overview
  7.3.3 Almirall Prescription Dermatological Medications Major Product Offerings
  7.3.4 Almirall Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.3.5 Almirall Key News
7.4 Bausch Health
  7.4.1 Bausch Health Corporate Summary
  7.4.2 Bausch Health Business Overview
  7.4.3 Bausch Health Prescription Dermatological Medications Major Product Offerings
  7.4.4 Bausch Health Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.4.5 Bausch Health Key News
7.5 Barrier Therapeutics
  7.5.1 Barrier Therapeutics Corporate Summary
  7.5.2 Barrier Therapeutics Business Overview
  7.5.3 Barrier Therapeutics Prescription Dermatological Medications Major Product Offerings
  7.5.4 Barrier Therapeutics Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.5.5 Barrier Therapeutics Key News
7.6 PharmaDerm
  7.6.1 PharmaDerm Corporate Summary
  7.6.2 PharmaDerm Business Overview
  7.6.3 PharmaDerm Prescription Dermatological Medications Major Product Offerings
  7.6.4 PharmaDerm Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.6.5 PharmaDerm Key News
7.7 Bristol-Myers Squibb
  7.7.1 Bristol-Myers Squibb Corporate Summary
  7.7.2 Bristol-Myers Squibb Business Overview
  7.7.3 Bristol-Myers Squibb Prescription Dermatological Medications Major Product Offerings
  7.7.4 Bristol-Myers Squibb Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.7.5 Bristol-Myers Squibb Key News
7.8 Galderma
  7.8.1 Galderma Corporate Summary
  7.8.2 Galderma Business Overview
  7.8.3 Galderma Prescription Dermatological Medications Major Product Offerings
  7.8.4 Galderma Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.8.5 Galderma Key News
7.9 Novartis
  7.9.1 Novartis Corporate Summary
  7.9.2 Novartis Business Overview
  7.9.3 Novartis Prescription Dermatological Medications Major Product Offerings
  7.9.4 Novartis Prescription Dermatological Medications Sales and Revenue in Global (2017-2022)
  7.9.5 Novartis Key News

8 GLOBAL PRESCRIPTION DERMATOLOGICAL MEDICATIONS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Prescription Dermatological Medications Production Capacity, 2017-2028
8.2 Prescription Dermatological Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Dermatological Medications Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PRESCRIPTION DERMATOLOGICAL MEDICATIONS SUPPLY CHAIN ANALYSIS

10.1 Prescription Dermatological Medications Industry Value Chain
10.2 Prescription Dermatological Medications Upstream Market
10.3 Prescription Dermatological Medications Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Prescription Dermatological Medications Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Prescription Dermatological Medications in Global Market
Table 2. Top Prescription Dermatological Medications Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Prescription Dermatological Medications Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Prescription Dermatological Medications Revenue Share by Companies, 2017-2022
Table 5. Global Prescription Dermatological Medications Sales by Companies, (K Units), 2017-2022
Table 6. Global Prescription Dermatological Medications Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Prescription Dermatological Medications Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Prescription Dermatological Medications Product Type
Table 9. List of Global Tier 1 Prescription Dermatological Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Dermatological Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prescription Dermatological Medications Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Prescription Dermatological Medications Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Prescription Dermatological Medications Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Prescription Dermatological Medications Sales (K Units), 2017-2022
Table 15. By Type - Global Prescription Dermatological Medications Sales (K Units), 2023-2028
Table 16. By Application – Global Prescription Dermatological Medications Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Prescription Dermatological Medications Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Prescription Dermatological Medications Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Prescription Dermatological Medications Sales (K Units), 2017-2022
Table 20. By Application - Global Prescription Dermatological Medications Sales (K Units), 2023-2028
Table 21. By Region – Global Prescription Dermatological Medications Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Prescription Dermatological Medications Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Prescription Dermatological Medications Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Prescription Dermatological Medications Sales (K Units), 2017-2022
Table 25. By Region - Global Prescription Dermatological Medications Sales (K Units), 2023-2028
Table 26. By Country - North America Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Prescription Dermatological Medications Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Prescription Dermatological Medications Sales, (K Units), 2017-2022
Table 29. By Country - North America Prescription Dermatological Medications Sales, (K Units), 2023-2028
Table 30. By Country - Europe Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Prescription Dermatological Medications Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Prescription Dermatological Medications Sales, (K Units), 2017-2022
Table 33. By Country - Europe Prescription Dermatological Medications Sales, (K Units), 2023-2028
Table 34. By Region - Asia Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Prescription Dermatological Medications Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Prescription Dermatological Medications Sales, (K Units), 2017-2022
Table 37. By Region - Asia Prescription Dermatological Medications Sales, (K Units), 2023-2028
Table 38. By Country - South America Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Prescription Dermatological Medications Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Prescription Dermatological Medications Sales, (K Units), 2017-2022
Table 41. By Country - South America Prescription Dermatological Medications Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Prescription Dermatological Medications Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Prescription Dermatological Medications Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Prescription Dermatological Medications Sales, (K Units), 2023-2028
Table 46. Mylan Pharmaceuticals Corporate Summary
Table 47. Mylan Pharmaceuticals Prescription Dermatological Medications Product Offerings
Table 48. Mylan Pharmaceuticals Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Prescription Dermatological Medications Product Offerings
Table 51. Pfizer Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Almirall Corporate Summary
Table 53. Almirall Prescription Dermatological Medications Product Offerings
Table 54. Almirall Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bausch Health Corporate Summary
Table 56. Bausch Health Prescription Dermatological Medications Product Offerings
Table 57. Bausch Health Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Barrier Therapeutics Corporate Summary
Table 59. Barrier Therapeutics Prescription Dermatological Medications Product Offerings
Table 60. Barrier Therapeutics Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. PharmaDerm Corporate Summary
Table 62. PharmaDerm Prescription Dermatological Medications Product Offerings
Table 63. PharmaDerm Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Bristol-Myers Squibb Corporate Summary
Table 65. Bristol-Myers Squibb Prescription Dermatological Medications Product Offerings
Table 66. Bristol-Myers Squibb Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Galderma Corporate Summary
Table 68. Galderma Prescription Dermatological Medications Product Offerings
Table 69. Galderma Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Novartis Corporate Summary
Table 71. Novartis Prescription Dermatological Medications Product Offerings
Table 72. Novartis Prescription Dermatological Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Prescription Dermatological Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Prescription Dermatological Medications Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Prescription Dermatological Medications Production by Region, 2017-2022 (K Units)
Table 76. Global Prescription Dermatological Medications Production by Region, 2023-2028 (K Units)
Table 77. Prescription Dermatological Medications Market Opportunities & Trends in Global Market
Table 78. Prescription Dermatological Medications Market Drivers in Global Market
Table 79. Prescription Dermatological Medications Market Restraints in Global Market
Table 80. Prescription Dermatological Medications Raw Materials
Table 81. Prescription Dermatological Medications Raw Materials Suppliers in Global Market
Table 82. Typical Prescription Dermatological Medications Downstream
Table 83. Prescription Dermatological Medications Downstream Clients in Global Market
Table 84. Prescription Dermatological Medications Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Prescription Dermatological Medications Segment by Type
Figure 2. Prescription Dermatological Medications Segment by Application
Figure 3. Global Prescription Dermatological Medications Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prescription Dermatological Medications Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prescription Dermatological Medications Revenue, 2017-2028 (US$, Mn)
Figure 7. Prescription Dermatological Medications Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prescription Dermatological Medications Revenue in 2021
Figure 9. By Type - Global Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 10. By Type - Global Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 11. By Type - Global Prescription Dermatological Medications Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 13. By Application - Global Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 14. By Application - Global Prescription Dermatological Medications Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 16. By Region - Global Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 17. By Country - North America Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 18. By Country - North America Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 19. US Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 24. Germany Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 25. France Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 33. China Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 37. India Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 39. By Country - South America Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 40. Brazil Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Prescription Dermatological Medications Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Prescription Dermatological Medications Sales Market Share, 2017-2028
Figure 44. Turkey Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Prescription Dermatological Medications Revenue, (US$, Mn), 2017-2028
Figure 48. Global Prescription Dermatological Medications Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Prescription Dermatological Medications by Region, 2021 VS 2028
Figure 50. Prescription Dermatological Medications Industry Value Chain
Figure 51. Marketing Channels